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platelet-rich plasma (PRP) when used with guided-tissue regeneration (GTR) and 
bioactive glass (BG) in the treatment of Class II furcation lesions. Material and Methods: 
Bilateral Class II furcation lesions were surgically created and allowed to become chronic 
in the mandibular third premolars of 9 dogs. The defects were randomly assigned to: A) 
GTR+BG and B) GTR+BG+PRP. Similar defects were created in the maxillary third premolars 
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new cementum, new bone, mineralized bone area, non-mineralized bone area, and residual 
BG particle area. Results: Data analysis showed a superior length of new cementum and a 
greater mineralized bone area for group B in both periods (p<0.05). The non-mineralized 
bone area was greater in the control group (p<0.05) in both periods. Conclusion: Within 
the limits of this study, it can be concluded that the use of PRP in the treatment of Class 
II furcation defects may enhance the amount of new cementum and provide a more 
mineralized bone in a shorter period of time.
Key words: Periodontal diseases. Platelet-rich plasma (PRP). Regeneration. Furcation 
defects. Dogs.
INTRODUCTION 
It is recognized that teeth with furcation 
involvement may undergo a more extensive and 
rapid clinical probing attachment loss and are 
lost with greater frequency than single-rooted 
teeth18. Although regeneration of periodontal 
tissue is the ultimate goal of periodontal therapy, 
regeneration is not a predictable healing outcome 
after conventional treatment.
With the advent of regenerative techniques, a 
new concept of periodontal treatment based on 
the principle of cellular selection and guided tissue 
regeneration5, permits the treatment of teeth with 
furcation lesions by conservative surgical methods. 
Various studies reported gains in horizontal and 
vertical clinical attachment, with complete closure 
of the furcation in up to 67% of the cases using 
different types of mechanical barriers20,24. Despite 
positive results based on reports of substantial 
attachment gain and bone fill of furcations, 
guided-tissue regeneration (GTR) is technique 
sensitive and could be associated with increased 
postoperative problems. A major drawback to 
expanded polytetrafluoroethylene (ePTFE) and 
other non-resorbable membranes is the need for 
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their removal after 4 to 6 weeks, often with a 
surgical procedure that adds to patient morbidity 
and may disturb the healing tissue30.
Bone replacement grafts have achieved similar 
results to GTR, demonstrating a 55% overall 
improvement, with either complete or partial 
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bioactive glass (BG) when compared to an ePTFE 
barrier may produce similar clinical results30. When 
used in a variety of periodontal and oral surgical 
applications, BG has shown positive clinical and 
histological outcomes6,16,27.
In the past decade, several cytokines, or growth 
factors, have received attention because they can 
regulate migration, attachment, proliferation and/
or differentiation of periodontal ligament cells 
into hard tissue cells and have been shown to 
enhance regeneration with in vivo experiments4,23. 
A convenient technique to obtain transforming 
growth factor  (TGF) and platelet-derived growth 
factor (PDGF) is by preparing autologous platelet-
rich plasma (PRP)14. PDGF has shown to exert a 
favorable effect on periodontal regeneration as 
measured by gain in clinical attachment and defect 
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Considering that the most favorable outcome of 
periodontal regenerative procedures in furcations 
lesions has been achieved with a combination 
of graft material and GTR14,15, the goal of the 
present study was to investigate, histologically and 
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PRP when used with GTR and BG in the treatment 
of Class II furcation lesions.
MATERIAL AND METHODS
Nine adult female mongrel dogs were included 
in the experiment (mean weight=15 kg). The study 
protocol has been approved by the Institutional 
Committee of Animals Research. The surgical 
procedures were performed under general 
anesthesia with intravenous injection of a 3% 
sodium pentobarbital solution (0.5 mL/kg). The 
maxillary and mandibular second and fourth 
premolars had been bilaterally extracted previously 
and the extraction sites had been allowed to heal 
for 2 months. Bilateral Class II furcation lesions 
were surgically created at the buccal aspect of 
mandibular third premolars. In order to create the 
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expose the alveolar buccal bone. Osteotomy was 
done in the furcation area with high-speed diamond 
burs with constant irrigation and with Nos. 1 and 
2 Oschenbein chisels. The furcations lesions were 
standardized with a millimeter probe and measured 
5.0 mm in the apico-occlusal direction and 2.0 mm 
in the buccolingual direction (Figure 1), following a 
technique previously described22.
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accumulation for a period of one month (Figure 
2). After this period, scaling and root planing was 
performed and a regimen of daily brushing plus 
topical application of 0.1% chlorhexidine gluconate 
was instituted for 7 days prior to the surgical 
procedures.
In the same day of the treatment of the 
mandibular defects, similar defects were created at 
the buccal aspect of maxillary third premolars and 
were exposed to plaque accumulation for 1 month. 
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maxillary defects were assigned to receive the same 
treatments.
Figure 1- Clinical aspect of Class II furcation defect (5x 
2 mm)
Figure 2-	
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with gutta-percha
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PRP Preparation
Blood was obtained several min before the 
administration of anesthesia. Three tubes (5 mL), 
containing 0.5 mL of 3.2% sodium citrate solution 
as an anticoagulant, were drawn from each dog. 
The tubes were centrifuged at 1,200 rpm for 10 
min at room temperature. The blood was thus 
separated into 3 basic parts: red blood cells (at 
the bottom of the tube), platelet enriched plasma 
(a discrete grey line in the middle of the tube) and 
platelet poor plasma (at the top of the tube). The 
portion corresponding to the platelet poor plasma 
was discarded from each tube and the remaining 
content was centrifuged again at 1,200 rpm for 15 
min. Four hundred microliter of the middle portion, 
corresponding to the platelet enriched plasma, were 
pipetted from each tube. In order to obtain the gel, 
30 μL of 10% calcium chloride was added to PRP 
and heated in a water bath at 37°C. The gel was 
achieved after a period of 10 to 15 min26.
Defect treatment
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on the buccal aspect of the experimental sites, 
the granulation tissue was removed by curettage, 
and the exposed root surface was instrumented. 
On the root surface, the base of the defect was 
marked with curettes to establish a landmark for 
the histomorphometric analysis. Each contralateral 
defect in each animal was randomly assigned to one 
of the following treatments:
GTR+BG (Perioglas, US Biomaterials, Alachua, 
FL, USA) – Control group: BG particles were applied 
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XT® Gore-tex, Gore Associates, Flagstaff, AZ, USA) 
was adapted to the defect;
GTR+BG+PRP - Test group: BG was incorporated 
to the PRP (1:1) and this assemblage was 
immediately taken to a water bath at 37ºC what 
enabled the formation of a mixture of the gel and 
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defect and an absorbable membrane (Resolut XT® 
Gore-tex, Gore Associates) was adapted to the 
defect.
Primary, tension-free wound closure was 
accomplished following defect treatment, with 
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interrupted sutures (Vicryl, Ethicon INC, São 
José dos Campos, SP, Brazil) in order to cover 
the membranes. Immediately after the surgeries, 
an intramuscular injection of penicillin (1.5 mL – 
150,000 IU) was given to the animal.
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the maxillary defects (2 defects/ animal) were 
randomly assigned to receive the same treatments 
(Group A and Group B).
Postoperative plaque control was performed 
by irrigation with a solution of 1% chlorhexidine 

J

\




!"
 
 
 
 
 #
 
 

anesthesia, with a perfusion of 10% neutral 
formalin solution. The jaws were dissected and 
the blocks containing the experimental specimens 
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of equal parts of 50% formic acid and 20% sodium 
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washed in running water, dehydrated and embedded 
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obtained from the tissue blocks longitudinally, 
in a buccolingual direction, in a way to obtain a 
panoramic view of the furcation area. The sections 
were stained with hematoxylin and eosin.
For histometric and descriptive histological 
analyses, 5 sections per site representing the 
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used to obtain the mean for each parameter in 
each dog, measured with an image analysis system 
(Image Pro Plus Version 3.0, Media Cybernetics, 
Silver Spring, MD, USA). The sections were blindly 
presented for measurements by one examiner.
Linear measurements
The following linear measurements (mm) were 
obtained in the mesial and distal roots under the 
furcation:
Defect extension (DE): linear extension of the 
total root surface between the two notches;
New cementum (NC): linear extension of the 
root surface covered by new cementum;
Connective Tissue Adaptation (CA): extension 
of the root surface covered by connective tissue 
without cementum.
New bone (NB): measured from a horizontal line 
connecting both notches (apical limit of the defect) 
to the most coronal extent of new bone.
Area measurements
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limit of the defect. The following parameters (mm2) 
were obtained by the point counting technique:
Mineralized bone area (MBA): portion of the 
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Residual BG particle area (RBG): portion of the 
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Non-mineralized bone area (NMBA): portion of 
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The measurements were performed using 
a microscope (Zeiss Axioskop 2, Carl Zeiss 
Instruments, Gottingen, Lower Saxony, Germany) 
with a 1.25/.035 objective associated with a video 
camera/computer/software (Image Pro Plus Version 
3.0, Media Cybernetics).
Statistical analysis
Mean values for each parameter were obtained 
per defect. The mean values for all groups were 
SUAID FF, CARVALHO MD, AMBROSANO GMB, NOCITI FH Jr, CASATI MZ, SALLUM EA
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determined using the individual means from the 
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normal distribution, two-way ANOVA was carried 
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different time periods and the interaction between 
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RESULTS
Clinical observations
Clinically, the healing response was favorable for 
all treatments. No suppuration or abscess formation 
was observed during the 90 days and no exposure 
of membranes was observed in both groups during 
the healing period. A clinical examination performed 
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gingival margin of all sites was clinically normal 
and positioned coronal to the fornix of the buccal 
furcation.
Histological observations
There were no cases of epithelial downgrowth, 
ankylosis or extensive root resorption observed 
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reactions indicating toxicity were observed. A 
similar healing pattern was observed in the two 
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defect (Figure 3).
Figure 3- Mesiodistal histologic section of Class II furcation lesion stained with hematoxilyn and eosin (H&E), (original 
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Site of the test group guided-tissue regeneration + bioactive glass + platelet-rich plasma (GTR+BG+PRP) after 45 days; 
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both periods however a greater mineralized bone area was observed for test group in both periods when compare with the 
control group
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A continuous layer of new cementum had formed 
in the specimens of both groups extending coronally 
from the apical notches to a varying degree. 
However, in the group B, a more evident layer of 
new cementum was observed in the fornix region 
(coronal portion of the defect). In both groups, 
some small areas of the defects presented a very 
dense connective tissue surrounding the remaining 
BG particles. However, connective tissue adaptation 
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surface seemed to be more frequent in group A.
Various defects in all groups presented bone 
surrounding BG particles and bone in direct contact 
with these graft particles (Figure 4). However, in 
Figure 4- A) Photomicrograph of a mesiodistal histologic section of Class II furcation lesion platelet-rich plasma + bioactive 
glass + guided-tissue regeneration (PRP+BG+GTR) 90 days after treatment defect (Masson Trichrome staining, original 
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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surrounded by new bone (NB), connective tissue (CT) and areas suggesting the presence of immature bone (IB) in contact 
with BG; B) Histologic section of the PRP+BG+GTR defect, 90 days after staining with hematoxilyn and eosin (H&E), 
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the new bone formation occurring around BG particles (arrows)
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                 Mean±SD
Parameters
Group A     (control group) Group B (test group)
45 days                   90 days 45 days              90 days
New cementum (mm) 9.46±1.23Ba  9.20±3.21Ba 12.10±1.88Aa 12.45±1.73Aa
Connective Tissue 
Adaptation (mm)
2.00±0.71Ba 1.84±1.87Ba 0.00±0.00 Aa 0.33±0.62Aa
New bone (mm) 3.68±1.11Aa 4.33±0.64Aa 4.60±0.39Aa 5.01±0.63Aa
Defect Extension 
(mm)
11.88±1.17Aa 11.14±2.80Aa 12.10±1.88Aa 12.78±1.41Aa
Table 1- Mean and Standard Deviation (SD) for the linear parameters evaluated after all the treatments (bioactive 
glass+guided-tissue regeneration and bioactive glass+platelet-rich plasma+guided-tissue regeneration) in both periods. 
Capital letters compare treatments within each time and non-capital letter compare times within each treatment. Means 
followed by different letters are statistically different
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bone with a more evident mineralized bone area 
with islands of highly cellular bone marrow. In 
group A, the bone presented larger marrow spaces 
what could indicate a more immature bone when 
compared to group B.
Histometric measurements
The histometric results are shown in Tables 1 
and 2. Data analysis showed a superior length of 
new cementum for group B in both periods (45 days 
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differences were observed between periods for the 
linear parameters for the two groups. The addition 
of PRP provided a greater mineralized bone area in 
both periods (p<0.05). The non-mineralized bone 
area was greater in the control group (p<0.05) 
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difference was observed in the area occupied by the 
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differences between periods were observed in the 
mineralized bone area and non-mineralized bone 
area (p<0.05).
DISCUSSION
The present study evaluated if the application 
of PRP on Class II furcation lesions would enhance 
periodontal regeneration when associated with 
GTR and bioactive glass (BG). Clinical reports have 
demonstrated that the association of GTR, bone 
substitutes and PRP could provide good results 
in the treatment of intrabony defects and class II 
furcation lesions, as revealed by gain in clinical 
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effect of the association of PRP with GTR and BG 
on periodontal regeneration of class II furcation 
lesions in dogs.
It has been demonstrated that when a bone graft 
or substitute is combined with the GTR procedure 
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is observed3,14,15. This advantage can be explained 
by the osteoconductive and/or osteoinductive 
properties of the graft materials. One of the bone 
substitutes that have been investigated is the 
BG, a material that has been suggested as an 
osteoconductive graft6,16,27. The use of BG in the 
present study was not associated with any foreign 
body reaction. Healing events such as ankylosis and 
root resorption were not observed. This observation 
is in agreement with previous studies using BG in 
animals7,29. It was observed that some remaining 
BG granules showed dissolution of their core with 
the formation of new bone, as described by Vogel, 
et al.28 (2001).
The sites treated with GRT+BG (Group A) 
showed new cementum formation and new 
bone regeneration in both periods. These results 
are in accordance with previous reports, which 
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of GTR and bone substitutes14,15. However, clinical 
studies do not provide information about the nature 
of the healing process after these procedures.
In contrast with previous studies13,18,22, in the 
present investigation, there were no instances of 
epithelial downgrowth in all sites. In similar defects, 
Andrade, et al.1 (2007) observed a correlation 
between the exposure of the membrane and the 
epithelial migration. The presence of epithelial 
tissue was observed in all histological sections of 
the sites that shown a membrane exposure and was 
ascribed to the degradation of the exposed portions 
of this material.
The use of PRP for periodontal regeneration 
has been based on the idea that this preparation 
contains polypeptide growth factors (PGFs). Some 
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the growth and differentiation of the periodontal 
ligament and alveolar bone cells and could be 
responsible for the clinical improvement observed 
in experimental sites4,23. Other interesting feature 
Platelet-rich plasma in the treatment of Class II furcation defects: a histometrical study in dogs
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Table 2- Mean and Standard Deviation (SD) for the area parameters evaluated after all the treatments (bioactive glass+guided-
tissue regeneration and bioactive glass+platelet-rich plasma+guided-tissue regeneration) in both periods 
                 Mean±SD
Parameters
Group A     (control group) Group B (test group)
45 days                   90 days 45 days              90 days
Mineralized  Bone 
Area (mm2)
4.66±1.52Bb 7.63±1.53Ba 9.20±2.31Ab 10.31±4,51Aa
Non-mineralized bone 
Area (mm2)
7.16±2.49Aa 4.10±0.63Ab 4.34±0.48Ba 2.58±0.69Bb
Residual BG particles 
Area (mm2)
1.77±0.51Aa 1.74±0.44Aa 1.72±0.80Aa 1.40±0.68Aa
Capital letters compare treatments within each time and non-capital letter compare times within each treatment. Means 
followed by different letters are statistically different
J Appl Oral Sci. 168
of PRP is its sticky consistency due to its high 
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work as a hemostatic agent aiding in stabilizing 
the graft material and the blood clot19. Blood clot 
immobilization has been suggested as an important 
event in the early phases of wound healing of 
periodontal regenerative procedures20,21.
It has been previously shown that PRP 
may stimulate PDL cells and fibroblastic cell 
proliferation10,11 but may suppress epithelial cell 
division in vitro17. Consequently, by ordering these 
cellular responses into a series of related events, 
PRP may facilitate wound-healing and tissue 
regeneration. In the present study, the sites in the 
Group B showed a superior cementum formation, 
in both observation periods, when compared with 
the sites of Group A (p<0.05). To the best of our 
knowledge, no study provided direct evidence that 
the PRP could stimulate the differentiation of cells 
from the periodontal ligament to cementoblasts, 
inducing cementogenesis. However, previous 
investigations have suggested that the treatment 
with recombinant growth factors, such as PDGF and 
IGF may enhance the formation of cementum on 
denuded dentin surfaces4. In addition to it, a similar 
result was observed when the PRP was associated 
with a subepithelial connective tissue graft for the 
treatment of gingival recessions created in dogs26.
The positive effect of PRP in the bone response 
was demonstrated by previous studies9,21 and 
could be evidenced in the present study by the 
largest area of mineralized bone observed in 
group B. Sites treated with PRP showed a superior 
mineralized bone area with a concomitant inferior 
non-mineralized bone area, in both periods, when 
compared with group A (p<0.05). However, the 
difference between treatments is more evident 
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mineralized bone in group B was almost twice the 
one observed in group A. This observation is in 
agreement with an in vitro study25 that suggested 
that PDGF acts upon osteoblastic cell proliferation, 
exerting most of its effects during the early phase 
of wound healing. Although the mineralized bone 
formation was superior in group B of the present 
study, it should be noticed that recent animals 
studies could not demonstrate that PRP increases 
bone regeneration when used in peri-implant bone 
defects9.
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the activations of gene expression and protein 
production. Also, the ideal platelet and growth 
factor concentrations to promote periodontal 
regeneration has not been established. Lacoste, et 
al.12 (2003) reported that growth factors may act 
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and this may be other explanation for the different 
results in studies with PRP. In the present study, the 
achieved percentage mean of platelet concentration 
was 227.02 % (mean of 463,015 platelets/μL) in 
relation to blood platelet count.
The technique to produce PRP used in this 
study was previously described by Suaid, et al.26 
(2008). This technique enables to produce a platelet 
concentration generally four times greater than the 
whole blood. Lacoste, et al.12 (2003) performed a 
study that measured the concentrations of bFGF, 
VEGF, PDGF-BB and TGF-1 released from platelet 
concentrate and whole blood, before and after 
the addition of calcium alone, thrombin alone and 
various concentrations of calcium and thrombin. 
They observed that calcium chloride, regardless 
of the use of thrombin, released platelet growth 
factors. In this study, the concentration of growth 
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endothelial cell proliferation in vitro12. Since the 
use of thrombin in this type of investigation is not 
allowed in our country, instead of thrombin, 10% 
calcium chloride was added to PRP and heated in a 
water bath at 37°C.
CONCLUSIONS
Within the limits of this animal study, it was 
concluded that PRP in association with GTR and 
BG may enhance the amount of new cementum 
and provide a more mineralized bone (mature) in a 
shorter period of time when applied to the treatment 
of class II furcation lesions in dogs. Future studies 
are required to clarify the mechanism of action of 
PRP in the periodontal regeneration process and 
the ideal platelet and growth factor concentrations 
to adequately promote periodontal regeneration.
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